Carterra Inc., the leading provider of technologies enabling high-throughput biology, today announced the launch of the ...

Probius to develop AI-powered point-of-care screening technology, eliminating sample preparation requirements and ...

A novel optogenetic screening platform enables control over previously intractable biological systems. Using the screening platform, scientists have been able to selectively activate the integrated ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Integrated Biosciences, a biotechnology company integrating optogenetics, chemistry and AI to discover small molecule therapeutics for age-related diseases, ...

AutoChamber™ and AutoBMD™ AI solutions will soon be available on Precision Imaging Network, with AI-CVD® planned next.

Muscles make up nearly 40% of the human body and power every move we make, from a child's first steps to recovery after ...

Researchers have developed the world's first real-world head-to-head testing platform to determine whether commercial artificial intelligence (AI) algorithms are fit for NHS use to detect disease in a ...

A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...

This comes as it recently extended the screening age to 74 and started transitioning to a population-based digital register.